Dr Mridul Malhotra

Dr. Mridul Malhotra is a highly regarded Medical Oncologist known for his patient-focused and evidence-based cancer care. He specialises in precision oncology, utilising genomic testing and molecular profiling to design personalised treatment strategies. His approach integrates the latest advancements in immunotherapy and targeted therapy while ensuring compassionate support throughout the cancer journey. Dr. Malhotra actively collaborates with multidisciplinary teams to deliver comprehensive oncology care and is deeply committed to patient education, advocacy, and early cancer awareness initiatives.

Educational Qualifications:

• MD (Medicine)
• DM (Medical Oncology) – Tata Memorial Hospital, Mumbai

Professional Experience:

• Consultant – Medical Oncology, Manipal Hospital, Dwarka, New Delhi
• Extensive experience in tertiary cancer care
• Expertise in multidisciplinary tumour board management
• Active involvement in patient education & oncology awareness programs

Professional Memberships & Fellowships:

• European Society of Medical Oncology (ESMO)
• American Society of Medical Oncology (ASCO)
• Indian Society of Medical and Pediatric Oncology (ISMPO)

Awards & Achievements:

• Dr. Mridul Malhotra received a prestigious travel grant for his poster presentation at the European Lung Cancer Congress (ELCC) 2019, which focused on the real-world experience of ALK-positive NSCLC patients in India, highlighting novel insights into disease management and his commitment to advancing oncology research and patient care.
• Dr. Mridul Malhotra was also awarded a travel grant for ESMO Asia 2017 (Singapore) for his paper presentation at the Indian Cancer Congress 2017, Bengaluru, which explored outcomes of second-line chemotherapy in advanced pancreatic cancers, based on a retrospective study conducted at Tata Memorial Hospital, Mumbai.

Publications:

• Extraadrenal Pheochromocytoma – Case Report of Refractory Hypertension
  Singh VP, Singh M, Malhotra M, Kumar A, Agarwal AK. Indian Heart Journal, Mar–Apr; 64(2):203–205
• An Uncommon Cause of Bilateral Peripheral Facial Nerve Paralysis
  Singh VP, Jain V, Malhotra M, Agarwal AK, Arya V. National Medical Journal of India, 2010 Sep–Oct; 23(5):312
• An Unusual Complication of Liver Abscess
  Singh VP, Agarwal AK, Malhotra M, Teengh DP. Journal of the Indian Academy of Clinical Medicine (JIACM), 2011; 12(1):73–75
• Prevalence of Diabetic Retinopathy in Type 2 Diabetes and Its Correlation with Clinical and Metabolic Factors
  Malhotra M, Lal AK, Singh VP, Malik PK, Arya V, Agarwal AK. Indian Journal of Diabetes & Developing Countries, 2014. DOI: 10.1007/s13410-013-0183-6
• Extranodal NK/T-Cell Lymphoma of the Nasal Type with Predominant T-Cell Markers: A Rare Subtype of a Rare Disease Entity
  Varshney A, Nanadan, Patidar R, Malhotra M, Behera M, Nagar M, Kataria SP. International Journal of Medicine and Public Health, 2015; 5(4):378–380
• Outcomes with Second-Line Chemotherapy in Advanced Pancreatic Cancers – A Retrospective Study from a Tertiary Cancer Centre in India
  Ramaswamy A, Parthiban S, Malhotra M, Kothari R, Goel A, Bhargava P, et al. Indian Journal of Cancer, 2018; 55:144–147
• Cross-Sectional Study of Temozolomide-Induced Chemotherapy-Induced Nausea and Vomiting in Patients with Glioma
  Malhotra M, Chandrasekharan A, Tonse R, Jalali R, Patil VM. Clinical Oncology, Volume 31, Issue 1, Page e85
• A Cross-Sectional Audit of Distress in Patients Undergoing Adjuvant Therapy or Follow-Up in Central Nervous System Malignancies
  Patil VM, Malhotra M, Tonse R, Deodhar J, Chandrasekharan A, Pande N, Bhattacharjee A, Jalali R. Neuro-Oncology Practice, npy046
• Antiemetic Prophylaxis with Temozolomide: An Audit from a Tertiary Care Centre
  Patil VM, Chandrasekharan A, Vallathol DH, Malhotra M, Abhinav R, Agarwal P, Rajpurohit A, Tonse R, Bhattacharjee A, Jalali R. Neuro-Oncology Practice, npz009. DOI: 10.1093/nop/npz009
• Radiogenomic Signatures of NSCLC Brain Metastases: A Potential Non-Invasive Imaging Marker for ALK Mutation
  Wadhwa S, Krishna G, Malhotra M, Prabhash K, Noronha V, Joshi A, Patil V, Mahajan A. Annals of Oncology, Volume 30, Supplement 2, April 2019, mdz066. DOI: 10.1093/annonc/mdz066
• Real-World Experience of ALK-Positive NSCLC from India
  Malhotra M, Noronha V, Joshi A, Patil V, Wadhwa S, Prabhash K. Annals of Oncology, Volume 30, Supplement 2, April 2019, mdz063.075. DOI: 10.1093/annonc/mdz063.075